Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Fred Levine who wrote (119)	9/9/1998 3:40:00 PM
From: David Wise	Read Replies (1) \| Respond to of 2515

Strange pattern over past month or 2 where big volume comes in, price goes up, then lower volume and price goes back down. Short of stock price manipulation, I can't explain this. My question is why the price goes down.

To: Fred Levine who wrote (119)	9/9/1998 3:43:00 PM
From: rebecca	Respond to of 2515

IMCL"S rise may possibly be related to 1.Piper Jaffrey conference which is ongoing today and tomorrow (not sure if IMCL is presenting) 2. Anergen's news release related to angiogenesis rebecca

To: Fred Levine who wrote (119)	10/11/1998 4:37:00 PM
From: flickerful	Respond to of 2515

....From the oft-off but single-day-influential Inside Wall Street column in BusinessWeek: ImClone was up 23/32, or 11.2 percent, to 7 1/8 after Jim McCamant, editor of Medical Technology Stock Letter, was quoted saying he believes the company is close to a deal involving a European pharmaceutical firm to either take a significant equity stake in the company or license ImClone's lead compound, C225. .... ["oft off" is a slight improvement from earlier accounts describing this column as "accuracy challenged", but not exactly a ringing endorsement...] from...Friday Midday Musings Wall Street Weighs Fed Rumor in Snapback Session By Aaron L. Task ABCNEWS.com from TheStreet.com N E W Y O R K, Oct. 9 abcnews.com